Charlotte Robinson

DocwireNews

In a recent update published in The Lancet Global Health, the International Society of Nephrology Global Kidney Health Atlas reported that countries in low-resource settings demonstrated &ldquo;substantially diminished capacity for kidney care delivery.&rdquo; The research assessed the availability, accessibility, quality, and affordability of medicines, kidney replacement therapy (KRT), and conservative kidney management (CKM).The report, authored by Aminu K. Bello, MD, PhD, et al, was based on results of a literature review of information on the prevalence of chronic kidney disease (CKD) from 161 countries that sought to determine the burden of CKD and estimate the incidence and prevalence of treated kidney failure.The study also incorporated data from a global survey of opinion leaders. Survey responses covered 167 (87%) of 191 countries and represented 97.4% (7.700 billion of 7.903 billion) of the world&rsquo;s population.The worldwide median prevalence of CKD was 9.5% (IQR, 5.9-11.7), with the highest prevalence in Eastern and Central Europe (12.8%; 11.9-14.1). Availability of key treatments was widespread. Chronic hemodialysis was available in 162 (98%) of 165 countries, chronic peritoneal dialysis in 130 (79%), and kidney transplantation in 116 (70%). Of 164 countries, 121 (74%) were able to provide KRT to more than 50% of people with kidney failure. CKM was available in 87 (53%) of 165 countries. Children could not access hemodialysis in 12 (19%) of 62 countries, peritoneal dialysis in three (6%), or kidney transplantation in three (6%).Costs of treatment were a burden on patients and access was limited among populations in low-resource countries. The annual median costs of KRT were $19,380 per person for hemodialysis, $18,959 for peritoneal dialysis, and $26,903 for the first year of kidney transplantation. Public funding for free hemodialysis at the point of delivery increased along with a country&rsquo;s income level; 74 (45%) of 166 countries provided for hemodialysis in this manner.The study also looked at the health care workforce as a contributing factor. The median global prevalence of nephrologists was 11.8 per million population (IQR, 1.8-24.8), with an 80-fold difference between low- and high-income countries. Differing degrees of health care workforce shortages were reported across regions and country income levels. A quarter of countries had national strategies for CKD (41 [25%] of 162), and 78 (48%) of 162 countries recognized CKD as a health priority.&ldquo;The data serve as an important baseline for evaluating the impacts of various initiatives to change [CKD] outcomes in the future, to measure progress in countries and regions over time,&rdquo; the authors stated.Source: <a href="https://doi.org/10.1016/s2214-109x(23)00570-3" target="_blank" rel="noopener">The Lancel Global Health</a>

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Kidney Care Suffers in Low-Resource Countries

Chronic Kidney Disease

A study found that countries in low-resource settings show substantially diminished capacity for kidney care delivery.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe